Document Detail


Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy.
MedLine Citation:
PMID:  10396355     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Maternal thyroid function during early pregnancy is an important determinant of early fetal brain development because the fetal thyroid is unable to produce any T4 before 12-14 weeks' gestation. Overt maternal hypothyroidism as seen in severe iodine-deficient areas is associated with severely impaired neurological development of the offspring. At present, it is not known whether low free T4 (fT4) levels during pregnancy in healthy women from iodine sufficient areas may affect fetal neurodevelopment. METHODS: Neurodevelopment was assessed at 10 months of age in a cohort of 220 healthy children, born after uncomplicated pregnancies and deliveries, using the Bayley Scales of Infant Development. Maternal TSH, fT4 and TPO antibody status were assessed at 12 and 32 weeks' gestation. Maternal gestational fT4 concentration was defined as an independent parameter for child development. RESULTS: Children of women with fT4 levels below the 5th (< 9.8 pmol/l, n = 11) and 10th (< 10.4 pmol/l, n = 22) percentiles at 12 weeks' gestation had significantly lower scores on the Bayley Psychomotor Developmental Index (PDI) scale at 10 months of age, compared to children of mothers with higher fT4 values (t test, mean difference: 14.1, 95% confidence interval (CI): 5.9-22 and 7.4, 95% CI: 1.1-13.9, respectively). At 32 weeks' gestation, no significant differences were found. In the group of women with the lowest 10th percentile fT4 concentrations at 12 weeks' gestation, a positive correlation was found between the mothers' fT4 concentration and children's PDI scores (linear regression, R: 0.46, P = 0.03). After correction for confounding variables, a fT4 concentration below the 10th percentile at 12 weeks' gestation was a significant risk factor for impaired psychomotor development (RR): 5.8, 95% CI: 1.3-12.6). CONCLUSIONS: Low maternal plasma fT4 concentrations during early pregnancy may be an important risk factor for impaired infant development.
Authors:
V J Pop; J L Kuijpens; A L van Baar; G Verkerk; M M van Son; J J de Vijlder; T Vulsma; W M Wiersinga; H A Drexhage; H L Vader
Related Documents :
9055105 - P3 event related evoked potentials in pregnancy.
21601225 - A newborn with pierre robin sequence after preconceptional mitoxantrone exposure of a f...
602715 - Hyperthyroidism during pregnancy treated with propylthiouracil. the significance of mat...
11005705 - Drug therapy for hyperthyroidism in pregnancy: safety issues for mother and fetus.
11035335 - Lactoferrin in intrauterine infection, human parturition, and rupture of fetal membranes.
7293665 - Effects of bromocriptine-induced pregnancy on prolactin-secreting pituitary tumours.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical endocrinology     Volume:  50     ISSN:  0300-0664     ISO Abbreviation:  Clin. Endocrinol. (Oxf)     Publication Date:  1999 Feb 
Date Detail:
Created Date:  1999-07-22     Completed Date:  1999-07-22     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0346653     Medline TA:  Clin Endocrinol (Oxf)     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  149-55     Citation Subset:  IM    
Affiliation:
Department of Social and Behavioural Sciences, University of Tilburg, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibodies / blood
Female
Humans
Infant
Iodide Peroxidase / immunology
Pregnancy / blood*,  immunology
Pregnancy Trimester, First / blood
Pregnancy Trimester, Third / blood
Prenatal Exposure Delayed Effects
Psychomotor Performance*
Regression Analysis
Risk Factors
Thyrotropin / blood
Thyroxine / blood*
Chemical
Reg. No./Substance:
0/Antibodies; 7488-70-2/Thyroxine; 9002-71-5/Thyrotropin; EC 1.11.1.8/Iodide Peroxidase
Comments/Corrections
Comment In:
Clin Endocrinol (Oxf). 1999 Feb;50(2):147-8   [PMID:  10396354 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Environmental determinants of the distribution of Phlebotomus orientalis in Sudan.
Next Document:  An atypical contiguous gene syndrome: molecular studies in a family with X-linked Kallmann's syndrom...